)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Solana Company
Solana Company (HSDT) investor relations material
Solana Company Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary11 Nov, 2026
Executive summary
Pacific Backbone launched, third-party stake reached 1.0M SOL, and staking, advisory and validator operations began generating recurring revenue as operating costs fell below Q1 levels.
Q3 net income of $105.2M was driven largely by non-cash digital-asset fair-value gains as SOL rose ~60%; quarter-end treasury held 2.4M SOL, valued at $288.2M.
Institutional engagement expanded across Asia-Pacific, with 40+ education sessions and workshops; strategy focuses on growing SOL per share through treasury, infrastructure and advisory services.
Financial highlights
Q3 revenue was $3.4M, including $3.3M of staking revenue, versus $697K in Q3 2025; 9M revenue was $9.5M.
Q3 gross profit was $2.7M on $617K cost of revenue, with ~82% gross margin; 9M gross profit was $8.6M.
Q3 operating income was $103.9M and net income $105.2M; diluted EPS was $1.17 versus a $32.89 loss per share YoY. 9M operating loss was $28.4M and net loss $24.9M.
Q3 G&A was $3.4M versus $5.5M YoY and below Q1's $5.2M and Q2's $11.1M; Q2 included ~$6.8M of non-recurring PoNS-divestiture severance. 9M G&A was $19.7M.
Outlook and guidance
Q4 priorities include growing Pacific Backbone third-party stake, assessing Hong Kong as a validator location, pursuing ISO 27001 certification, expanding institutional adoption and compounding SOL per share.
G&A is expected to normalize between current and historic run rates as operations grow; no forward OpEx guidance was provided.
Third-party stake growth may slow in Q4 after rising from a few hundred thousand SOL to over 1M; further adoption-driven growth is expected by Q1 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Solana Company
- Q2 2026 revenue surged on staking, but net loss widened amid SOL losses and restructuring.HSDT
Q2 2026 - All director nominees and the auditor appointment were approved without shareholder questions.HSDTAGM 2026
- Director nominee withdrawn, board size reduced, and new CEO and CFO appointed.HSDTProxy filing
- Q1 2026 revenue surged on staking, but SOL volatility drove a $99.8M net loss.HSDTQ1 2026
- Shareholders will vote on director elections, auditor ratification, and board changes at the virtual annual meeting.HSDTProxy filing
- Annual meeting to elect directors, ratify auditor, and reinforce governance and sustainability.HSDTProxy filing
- Q4 2025 delivered strong staking rewards, $325.6M net income, and 14% SOL per share growth.HSDTQ4 2025
- CMS pricing delays hinder access and commercialization, prompting strategic review and regulatory focus.HSDTStatus Update
- First third-party reimbursement and Medicare rates expected to drive late-2024 revenue growth.HSDTQ2 2024
Next Solana Company earnings date
Q4 202630 Mar, 2027
Solana Company
Next Solana Company earnings date
Q4 202630 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Helius Medical Technologies Inc. is a neurotechnology company focused on developing non-invasive treatments for neurological conditions. The company’s primary product, the Portable Neuromodulation Stimulator (PoNS), is designed to help improve balance and gait in patients with neurological diseases or trauma, such as multiple sclerosis and traumatic brain injury. The PoNS® device stimulates the brain through the tongue, promoting neuroplasticity and aiding in physical rehabilitation. Helius Medical Technologies aims to offer innovative therapeutic solutions to enhance the quality of life for individuals with neurological impairments. The company is headquartered in Newtown, Pennsylvania, and its shares are listed on the NASDAQ.